ACORDA THERAPEUTICS INC (ACOR)

US00484M7002 - Common Stock

0.661  -0.22 (-24.86%)

After market: 0.5656 -0.1 (-14.43%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
117.63M118.60M129.10M153.00M192.40M
Minority Interest Expense
N/AN/AN/AN/AN/A
Cost Of Goods
15.28M30.30M40.80M33.50M34.80M
Gross Profit
102.35M88.20M88.30M119.50M157.60M
Operating Expenses
115.98M123.30M161.30M135.50M191.70M
Research and Development
11.00K100.00K700.00K1.70M2.80M
Selling, General, and Administrative Expenses
89.70M106.00M119.00M152.60M192.80M
Operating Income
-13.63M-35.00M-73.00M-16.10M-34.10M
Interest Income/Expense
-31.29M-28.30M-30.00M-29.80M-17.70M
Other Income/Expense
51.00K1.30M0.00200.00K0.00
Non Recurring Items
-251.32M26.80M-6.00M-62.00M-222.50M
Income Before Taxes
-296.02M-35.20M-109.10M-107.70M-274.20M
Income Tax
-43.17M30.70M-5.10M-8.10M-1.30M
Net Income
-252.85M-65.90M-104.00M-99.60M-273.00M
EBITDA
18.04M-2.20M-39.00M25.20M500.00K
 
Per Share Data
EPS Diluted Total Ops
-203.59-65.90-208.00-248.99-682.50
Non GAAP EPS
N/AN/A-6.43-9.04-10.32
 
Statistics
Gross Profit Margin
87.01%74.37%68.40%78.10%81.91%
Profit Margin
-214.95%-55.56%-80.56%-65.10%-141.89%
Operating Profit Margin
-11.59%-29.51%-56.55%-10.52%-17.72%

All data in USD

Charts